Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 250,321 | 271,466 | 199,097 | 247,796 | 314,684 |
| Marketable Securities | 129,475 | 120,452 | 216,785 | 226,954 | 348,924 |
| Receivables | 67,766 | 60,046 | 48,209 | 35,212 | 42,206 |
| TOTAL | $461,594 | $465,032 | $483,791 | $521,442 | $715,540 |
| Non-Current Assets | |||||
| PPE Net | 215,169 | 195,408 | 109,840 | 142,035 | 72,825 |
| Investments And Advances | 57,200 | 72,845 | 78,460 | 51,061 | 27,603 |
| Other Non-Current Assets | 8,229 | 9,060 | 9,330 | 9,682 | 9,923 |
| TOTAL | $280,598 | $277,313 | $197,630 | $202,778 | $110,351 |
| Total Assets | $742,192 | $742,345 | $681,421 | $724,220 | $825,891 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 55,291 | 51,881 | 44,832 | 36,168 | 41,887 |
| TOTAL | $114,165 | $120,424 | $103,113 | $83,672 | $217,771 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 58,874 | 68,543 | 58,281 | 47,504 | 58,381 |
| aiOther Non-Current Liabilities | 3,341 | 1,235 | 13,150 | 2,431 | 2,885 |
| TOTAL | $205,584 | $211,415 | $167,988 | $219,034 | $171,187 |
| Total Liabilities | $319,749 | $331,839 | $271,101 | $302,706 | $388,958 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,494 | 80,179 | 80,092 | 79,977 | 79,648 |
| Common Shares | 80 | 80 | 80 | 80 | 79 |
| Retained earnings | -904,606 | -903,591 | -893,408 | -873,265 | -844,409 |
| Other shareholders' equity | 3,537 | 1,014 | -1,248 | -114 | -3,960 |
| TOTAL | $422,443 | $410,506 | $410,320 | $421,514 | $436,933 |
| Total Liabilities And Equity | $742,192 | $742,345 | $681,421 | $724,220 | $825,891 |